Anavex Life Sciences Corp (AVXL)

[falconer66a]

The favorable insomnia outcomes of Anavex 2-73 in the Australian clinical trial have not been much considered. They should be. Should the drug prove to be a universal and safe treatment of insomnia in the upcoming Phase 3 clinical trial, the implications (to use a now-common phrase) will be H U G E. According to Wikipedia, “Between 10% and 30% of adults have insomnia at any given point in time and up to half of people have insomnia in a given year....”

What if a low dosage of Anavex 2-73 provides universal insomnia relief? Would there not be a chance that at first, the drug gets prescribed for insomnia, followed sometime later with over the counter sales?

This will be another useful determination of the big Phase 3 study.

I don’t believe the entirety of Anavex 2-73 clinical applications have yet been discovered.